Editorial: Advancing gene and cell therapy using human mesenchymal stem cells

Tong Ming Liu; Yingnan Wu

doi:10.3389/fcell.2023.1294460

Editorial: Advancing gene and cell therapy using human mesenchymal stem cells

Front Cell Dev Biol. 2023 Oct 13:11:1294460. doi: 10.3389/fcell.2023.1294460. eCollection 2023.

Authors

Tong Ming Liu¹, Yingnan Wu^{2

3}

Affiliations

¹ Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
² Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
³ NUS Tissue Engineering Program, Life Sciences Institute, National University of Singapore, Singapore, Singapore.

No abstract available

Keywords: MSC-EVs; cell therapy; gene therapy; mesenchymal stem cells; senescence.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the A*STAR Career Development Award (C210112047 to TL) and pre-gap funding (I22D1AG050 to TL).